Literature DB >> 27570432

Neuroendocrine carcinoma of the extrahepatic bile duct: A case report.

Yukio Oshiro1, Ryozo Gen1, Shinji Hashimoto1, Tatsuya Oda1, Taiki Sato1, Nobuhiro Ohkohchi1.   

Abstract

Neuroendocrine carcinoma (NEC) originating from the gastrointestinal hepatobiliary-pancreas is a rare, invasive, and progressive disease, for which the prognosis is extremely poor. The patient was a 72-year-old man referred with complaints of jaundice. He was diagnosed with middle extrahepatic cholangiocarcinoma (cT4N1M0, cStage IV). He underwent a right hepatectomy combined with extrahepatic bile duct and portal vein resection after percutaneous transhepatic portal vein embolization. Microscopic examination showed a large-cell neuroendocrine carcinoma according to the WHO criteria for the clinicopathologic classification of gastroenteropancreatic neuroendocrine tumors. Currently, the patient is receiving combination chemotherapy with cisplatin and etoposide for postoperative multiple liver metastases. Although NEC is difficult to diagnose preoperatively, it should be considered an uncommon alternative diagnosis.

Entities:  

Keywords:  Extrahepatic bile duct; Neuroendocrine carcinoma; Neuroendocrine tumor

Mesh:

Year:  2016        PMID: 27570432      PMCID: PMC4974594          DOI: 10.3748/wjg.v22.i30.6960

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  [Two cases of neuroendocrine carcinoma in the biliary system with long-term survival].

Authors:  Masaru Baba; Ken Furuya; Tadashi Koizumi; Kenji Kasai; Kuniaki Sadaoka; Chihiro Sekiya; Atsuo Hattori
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2012-09

2.  Well-differentiated endocrine carcinoma originating from the bile duct in association with a congenital choledochal cyst.

Authors:  Kazuhiro Takahashi; Ryoko Sasaki; Yukio Oshiro; Kiyoshi Fukunaga; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  Int Surg       Date:  2012 Oct-Dec

3.  Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours.

Authors:  Jaihwan Kim; Woo Jin Lee; Sang Hyub Lee; Kyoung Bun Lee; Ji Kon Ryu; Yong-Tae Kim; Sun-Whe Kim; Yong Bum Yoon; Jin Hyeok Hwang; Ho-Seong Han; Sang Myung Woo; Sang Jae Park
Journal:  Dig Liver Dis       Date:  2011-12       Impact factor: 4.088

4.  Carcinoid tumor of the extrahepatic bile duct: report of a case.

Authors:  Takeo Yasuda; Gen Imai; Masako Takemoto; Mitsuo Yamasaki; Hajime Ishikawa; Masayuki Kitano; Takuya Nakai; Yoshifumi Takeyama
Journal:  Clin J Gastroenterol       Date:  2013-03-23

5.  Composite small cell and mucinous carcinoma originating from the intrahepatic bile duct: report of a case.

Authors:  Toru Ikegami; Hiroto Kayashima; Noriaki Sadanaga; Shusuke Morizono; Akihiko Nakashima; Hiroshi Matsuura; Ken Shirabe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-09-22       Impact factor: 2.549

Review 6.  Carcinoid tumor of the common bile duct: evidence for its origin in metaplastic endocrine cells.

Authors:  L P Barrón-Rodríguez; J C Manivel; N Méndez-Sánchez; J Jessurun
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

7.  Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.

Authors:  Satoru Iwasa; Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Shunsuke Kondo; Tsutomu Tanaka; Kohei Nakachi; Shuichi Mitsunaga; Yasushi Kojima; Atsushi Hagihara; Nobuyoshi Hiraoka
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019

8.  Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.

Authors:  Jorge Albores-Saavedra; Kristen Batich; Sarah Hossain; Donald E Henson; Arnold M Schwartz
Journal:  Ann Diagn Pathol       Date:  2009-12       Impact factor: 2.090

9.  A case report of primary neuroendocrine carcinoma of the perihilar bile duct.

Authors:  Yasuhiro Kihara; Hiroshi Yokomizo; Takahiro Urata; Michiko Nagamine; Toshihiko Hirata
Journal:  BMC Surg       Date:  2015-12-10       Impact factor: 2.102

  9 in total
  7 in total

1.  Primary extrahepatic bile duct neuroendocrine tumor with obstructive jaundice masquerading as a Klatskin tumor.

Authors:  Lauren Hoepfner; Jared A White
Journal:  J Surg Case Rep       Date:  2017-06-05

2.  Nonfunctional pancreatic neuroendocrine tumor masked as anemia: A case report.

Authors:  Baojin Xu; Yue Wang; Xiaoyan Li; Jie Lin
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Neuroendocrine tumor of the common bile duct: a case report and review of the literature.

Authors:  Zhong Liu; Deng-Yong Zhang; Zheng Lu; Pei Zhang; Wan-Liang Sun; Xiang Ma; Hua Wu; Bin-Quan Wu; Shuo Zhou
Journal:  Onco Targets Ther       Date:  2018-04-23       Impact factor: 4.147

Review 4.  Neuroendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review.

Authors:  Liang Zhang; DaLong Wan; Li Bao; Qing Chen; HaiYang Xie; ShiGuo Xu; ShengZhang Lin
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Mixed adenoendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review.

Authors:  Liang Zhang; Zhengtao Yang; Qing Chen; Mengxia Li; Xiaolu Zhu; Dalong Wan; Haiyang Xie; Shusen Zheng
Journal:  Oncol Lett       Date:  2019-06-20       Impact factor: 2.967

6.  Neuroendocrine carcinoma of the common bile duct associated with congenital bile duct dilatation: a case report.

Authors:  Yoshitaka Kiya; Yuichi Nagakawa; Chie Takishita; Hiroaki Osakabe; Hitoe Nishino; Masanori Akashi; Hiroshi Yamaguchi; Toshitaka Nagao; Ryo Oono; Kenji Katsumata; Akihiko Tsuchida
Journal:  BMC Gastroenterol       Date:  2021-06-12       Impact factor: 3.067

7.  Neuroendocrine Tumor of the Common Bile Duct: Case Report.

Authors:  Ricardo Fernández-Ferreira; Emilio Medina-Ceballos; Pamela Denisse Soberanis-Piña; Emilio Conde-Flores; Andrés Mauricio Arroyave-Ramírez; Carlos Daniel Izquierdo-Tolosa; Daniel Motola-Kuba; Jose Manuel Ruiz-Morales; Rita Dorantes-Heredia
Journal:  Case Rep Oncol       Date:  2021-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.